Not an actual patient.

Find
Your
Way Forward

With Diffuse Large B-cell
Lymphoma (DLBCL)

Whether it is a first diagnosis, or relapsed or refractory DLBCL, DLBCL Support Source is here to provide information and support to help you make sense of your diagnosis and understand your next steps.

Understanding the
Journey Ahead

This shows how a person’s journey with DLBCL may progress over time. Remember, every person is unique. Your healthcare team will work with you to help develop a plan that’s right for you. Don’t be afraid to ask questions; your healthcare team is your best source of information.

First Diagnosis

Finding out that you or a loved one has DLBCL can be overwhelming, and it’s natural to feel a range of emotions. It’s important to remember you are not alone. Your healthcare team will work with you to help you determine your next steps.

Learn more about this disease >

First-line DLBCL Treatment

It’s important to understand that there are treatment options available for people with DLBCL. Your healthcare team will work with you to determine a disease management plan that best meets your needs.

Chemoimmunotherapy

is often used to treat first-line DLBCL.

Learn more about treatment approaches >

Not actual patients or
healthcare provider.

DLBCL Responds
to Treatment

After treatment for a first diagnosis of DLBCL, 50% to 60% of people achieve remission. This means that the signs and symptoms of DLBCL have decreased (known as partial remission), or disappeared (known as complete remission).

DLBCL May
Become Relapsed

Sometimes, DLBCL may return following a period of remission after treatment. This is known as “relapse,” and it may occur in 30% to 40% of people treated for DLBCL.

Learn more about relapsed DLBCL>

DLBCL May Be
Refractory

At times, DLBCL may not respond to a first treatment. This is known as “refractory DLBCL,” and it occurs in about 10% of people following treatment.

Learn more about refractory DLBCL>

Second-line Treatment

Even if DLBCL relapses or becomes refractory, it is important not to lose hope. There are still treatment options and management approaches that may be available for people with relapsed or refractory DLBCL. Your healthcare team will work with you to develop a treatment plan that best meets your needs.

Chemotherapy

These drugs treat cancer by killing rapidly dividing cells throughout the body or by stopping them from dividing. Chemotherapy can be given alone or in combination with other treatment options. Chemotherapy may be given orally, by injection under the skin, or intravenously and can affect both normal and cancer cells.

Targeted Therapy

A type of cancer treatment that helps block the growth and spread of cancer by interfering with specific molecular targets on cancer cells. These treatments can affect both normal and cancer cells.

Stem-Cell Transplant

All blood cells are formed from special cells called blood stem cells, which can be damaged or destroyed by radiation or high-dose chemotherapy. A stem-cell transplant replaces damaged or destroyed cells with healthy stem cells.

CAR-T Therapy

An abbreviation for “chimeric antigen receptor T-cell” therapy. A type of cancer treatment in which a type of immune cells called T cells are taken from a patient’s blood and modified in the laboratory so they will attack cancer cells.

Not actual
healthcare
providers.

Looking for Support? Find It Here!

Whether you are a person living with DLBCL or a caregiver, support is available.

Not actual
healthcare providers.

Are You a Patient or Caregiver?

Whether you are a person living with DLBCL, or you care for someone with the disease, find information and support specific to your situation.

Not an actual patient.

Support for People
With DLBCL

Find education and support information for people living with DLBCL.

Not actual patients
or caregivers.

Support for Caregivers

Caregivers play an important role in the lives of those with DLBCL. Find support here.

Not an actual patient
or caregiver.

Not an actual patient
or caregiver.

Ready to take a more active role in your care? Download a shared decision-making toolkit

Download the toolkit

Not an actual patient
or caregiver.